Uncategorized
LUMINOUS interim analysis shows high intercountry variability of baseline characteristics
NICE, France — The second interim analysis at 3 years of the LUMINOUS study showed high diversity of baseline characteristics across distinct geographies in terms of patient age, interval from diagnosis to treatment, and prevalence of pigment epithelium detachment and polypoidal choroidal vasculopathy. “The LUMINOUS study has now reached the target enrollment of 30,000 patients. The purpose of this analysis was to describe the baseline characteristics of 17,546 patients with neovascular AMD across multiple countries recruited prior to March 2014,” Paul Mitchell, MD, said at the Euretina meeting.